Hopicox-MR Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal disorders. Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective analgesic and anti-inflammatory effects by selectively blocking the COX-2 enzyme, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation while minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Thiocolchicoside, a muscle relaxant with anti-inflammatory properties, acts by inhibiting excitatory neurotransmission in muscle fibers, leading to relief from muscle spasms and stiffness. The combination of these agents offers a synergistic approach, addressing both pain and muscle spasm, thereby improving patient mobility and quality of life. Hopicox-MR is indicated for short-term use under medical supervision, and caution is advised in patients with cardiovascular disease, hepatic or renal impairment, and gastrointestinal disorders. Common adverse effects may include gastrointestinal discomfort, dizziness, and allergic reactions. It is contraindicated in patients with hypersensitivity to either component, active peptic ulcer, or severe hepatic impairment. Consultation with a healthcare professional is essential before initiating therapy.